Viewing Study NCT04331093

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 1:18 AM

Ignite Modification Date: 2025-12-25 @ 11:26 PM

Study NCT ID: NCT04331093

Status: RECRUITING

Last Update Posted: 2021-05-26

First Post: 2020-03-31

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Sponsor: Di Wu

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module